Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Apr 24, 2024

SELL
$221.9 - $484.47 $221,900 - $484,470
-1,000 Closed
0 $0
Q2 2021

Apr 24, 2024

BUY
$129.91 - $234.98 $129,910 - $234,980
1,000 New
1,000 $235 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bulltick Wealth Management, LLC Portfolio

Follow Bulltick Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.